AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis

NASDAQ:AVAH • US05356F1057

7.38 USD
-0.05 (-0.67%)
Last: Mar 3, 2026, 02:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall AVAH gets a fundamental rating of 5 out of 10. We evaluated AVAH against 101 industry peers in the Health Care Providers & Services industry. While AVAH is still in line with the averages on profitability rating, there are concerns on its financial health. AVAH is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • AVAH had positive earnings in the past year.
  • In the past year AVAH had a positive cash flow from operations.
  • AVAH had negative earnings in each of the past 5 years.
  • In multiple years AVAH reported negative operating cash flow during the last 5 years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.17%, AVAH is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 761.17%, AVAH belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
  • The Return On Invested Capital of AVAH (13.25%) is better than 89.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AVAH is below the industry average of 9.12%.
  • The 3 year average ROIC (5.94%) for AVAH is below the current ROIC(13.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROIC 13.25%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K

1.3 Margins

  • The Profit Margin of AVAH (3.29%) is better than 71.29% of its industry peers.
  • Looking at the Operating Margin, with a value of 10.25%, AVAH is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
  • AVAH's Operating Margin has improved in the last couple of years.
  • AVAH has a better Gross Margin (33.57%) than 65.35% of its industry peers.
  • In the last couple of years the Gross Margin of AVAH has remained more or less at the same level.
Industry RankSector Rank
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AVAH is still creating some value.
  • AVAH has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AVAH has been increased compared to 5 years ago.
  • AVAH has a better debt/assets ratio than last year.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • AVAH has an Altman-Z score of 1.24. This is a bad value and indicates that AVAH is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AVAH (1.24) is worse than 62.38% of its industry peers.
  • AVAH has a debt to FCF ratio of 17.78. This is a negative value and a sign of low solvency as AVAH would need 17.78 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 17.78, AVAH is in line with its industry, outperforming 41.58% of the companies in the same industry.
  • AVAH has a Debt/Equity ratio of 130.05. This is a high value indicating a heavy dependency on external financing.
  • AVAH has a Debt to Equity ratio of 130.05. This is amonst the worse of the industry: AVAH underperforms 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Altman-Z 1.24
ROIC/WACC1.36
WACC9.74%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that AVAH should not have too much problems paying its short term obligations.
  • AVAH has a Current ratio (1.23) which is in line with its industry peers.
  • A Quick Ratio of 1.23 indicates that AVAH should not have too much problems paying its short term obligations.
  • AVAH has a Quick ratio of 1.23. This is comparable to the rest of the industry: AVAH outperforms 51.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • AVAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2500.00%, which is quite impressive.
  • Measured over the past years, AVAH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -49.58% on average per year.
  • The Revenue has grown by 15.48% in the past year. This is quite good.
  • Measured over the past years, AVAH shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%

3.2 Future

  • Based on estimates for the next years, AVAH will show a very strong growth in Earnings Per Share. The EPS will grow by 100.99% on average per year.
  • The Revenue is expected to grow by 8.86% on average over the next years. This is quite good.
EPS Next Y1073%
EPS Next 2Y251.18%
EPS Next 3Y139.23%
EPS Next 5Y100.99%
Revenue Next Year20.65%
Revenue Next 2Y13.07%
Revenue Next 3Y10.5%
Revenue Next 5Y8.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.38, AVAH is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of AVAH indicates a rather cheap valuation: AVAH is cheaper than 81.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, AVAH is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 11.97, which indicates a very decent valuation of AVAH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AVAH indicates a rather cheap valuation: AVAH is cheaper than 84.16% of the companies listed in the same industry.
  • AVAH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.11.
Industry RankSector Rank
PE 15.38
Fwd PE 11.97
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AVAH is valued a bit cheaper than 65.35% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AVAH is valued a bit cheaper than 65.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.68
EV/EBITDA 12.52
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AVAH has a very decent profitability rating, which may justify a higher PE ratio.
  • AVAH's earnings are expected to grow with 139.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y251.18%
EPS Next 3Y139.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AVAH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (3/3/2026, 2:01:30 PM)

7.38

-0.05 (-0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners23.38%
Inst Owner Change0.32%
Ins Owners5.67%
Ins Owner Change5.24%
Market Cap1.54B
Revenue(TTM)2.29B
Net Income(TTM)75.46M
Analysts77.65
Price Target11.33 (53.52%)
Short Float %8.03%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)232.09%
Min EPS beat(2)51.78%
Max EPS beat(2)412.4%
EPS beat(4)4
Avg EPS beat(4)2370.21%
Min EPS beat(4)51.78%
Max EPS beat(4)6955.89%
EPS beat(8)8
Avg EPS beat(8)1242.78%
EPS beat(12)10
Avg EPS beat(12)826.72%
EPS beat(16)10
Avg EPS beat(16)602.5%
Revenue beat(2)2
Avg Revenue beat(2)5.46%
Min Revenue beat(2)2.96%
Max Revenue beat(2)7.96%
Revenue beat(4)4
Avg Revenue beat(4)4.95%
Min Revenue beat(4)2.02%
Max Revenue beat(4)7.96%
Revenue beat(8)7
Avg Revenue beat(8)2.57%
Revenue beat(12)10
Avg Revenue beat(12)2.07%
Revenue beat(16)11
Avg Revenue beat(16)0.9%
PT rev (1m)3.63%
PT rev (3m)5.19%
EPS NQ rev (1m)2.67%
EPS NQ rev (3m)27.27%
EPS NY rev (1m)1.23%
EPS NY rev (3m)23.57%
Revenue NQ rev (1m)0.68%
Revenue NQ rev (3m)4.8%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)3.83%
Valuation
Industry RankSector Rank
PE 15.38
Fwd PE 11.97
P/S 0.67
P/FCF 18.68
P/OCF 17.22
P/B 155.51
P/tB N/A
EV/EBITDA 12.52
EPS(TTM)0.48
EY6.5%
EPS(NY)0.62
Fwd EY8.36%
FCF(TTM)0.39
FCFY5.35%
OCF(TTM)0.43
OCFY5.81%
SpS10.96
BVpS0.05
TBVpS-5.75
PEG (NY)0.01
PEG (5Y)N/A
Graham Number0.72
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 761.17%
ROCE 16.77%
ROIC 13.25%
ROICexc 14.79%
ROICexgc 415.4%
OM 10.25%
PM (TTM) 3.29%
GM 33.57%
FCFM 3.6%
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexgc growth 3Y3.46%
ROICexgc growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 130.05
Debt/FCF 17.78
Debt/EBITDA 5.62
Cap/Depr -130.77%
Cap/Sales 0.31%
Interest Coverage 1.56
Cash Conversion 39.02%
Profit Quality 109.35%
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1.24
F-Score8
WACC9.74%
ROIC/WACC1.36
Cap/Depr(3y)53.12%
Cap/Depr(5y)65.29%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2500%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%650%
EPS Next Y1073%
EPS Next 2Y251.18%
EPS Next 3Y139.23%
EPS Next 5Y100.99%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%22.18%
Revenue Next Year20.65%
Revenue Next 2Y13.07%
Revenue Next 3Y10.5%
Revenue Next 5Y8.86%
EBIT growth 1Y90.23%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year112.38%
EBIT Next 3Y31.78%
EBIT Next 5Y24.44%
FCF growth 1Y469.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y715.42%
OCF growth 3YN/A
OCF growth 5YN/A

AVEANNA HEALTHCARE HOLDINGS / AVAH FAQ

What is the ChartMill fundamental rating of AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AVAH.


What is the valuation status for AVAH stock?

ChartMill assigns a valuation rating of 8 / 10 to AVEANNA HEALTHCARE HOLDINGS (AVAH). This can be considered as Undervalued.


How profitable is AVEANNA HEALTHCARE HOLDINGS (AVAH) stock?

AVEANNA HEALTHCARE HOLDINGS (AVAH) has a profitability rating of 6 / 10.


What is the valuation of AVEANNA HEALTHCARE HOLDINGS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AVEANNA HEALTHCARE HOLDINGS (AVAH) is 15.38 and the Price/Book (PB) ratio is 155.51.


Can you provide the expected EPS growth for AVAH stock?

The Earnings per Share (EPS) of AVEANNA HEALTHCARE HOLDINGS (AVAH) is expected to grow by 1073% in the next year.